The company was founded in 2021 by Prof. Elin Esbjörner Winters and Prof. Marcus Wilhelmsson together with four scientists from their respective academic research groups at Chalmers University of Technology. The two groups have a leading position in nucleic acid label development, microscopy/spectroscopy of nucleic acids, and understanding of drug delivery processes. 

The company's patent pending technologies originate from the industrial research centre for functional RNA delivery - FoRmulaEx - where three academic partners carry out research in close cooperation with pharma/biotech companies. The aim is to contribute with fundamental knowledge required for the design of safe and efficient nanoscale drug-delivery vehicles for next generation nucleotide drugs.

In 2021 Prof. Esbjörner Winters and Prof. Wilhelmsson jointly were awarded the yearly Areas of Advance Award for their contributions to this field of research. Moreover, for the recent published methodology their research has been appointed as one of the best research project ideas for commercialization in an exclusive list compiled by the Royal Swedish Academy of Engineering Sciences.